Suppression of herpes simplex virus 1 reactivation in a mouse eye model by cyclooxygenase inhibitor, heat shock protein inhibitor, and adenosine monophosphate

Japanese Journal of Ophthalmology

Volumn 54, Issue 3, 2010, Pages 187-190

  Shimomura, Yoshikazu ^a   Higaki, Shiro ^a   Watanabe, Keizo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AMP; COX inhibitor; HSP inhibitor; HSV 1 latency; HSV 1 reactivation

Indexed keywords

ADENOSINE PHOSPHATE; ASCORBIC ACID; BROMFENAC; BRONUCK; ETODOLAC; GELDANAMYCIN; PRANOPROFEN; PRORANON; UNCLASSIFIED DRUG; VIRUS DNA; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; DRUG EFFICACY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; TRIGEMINUS GANGLION; VIRUS INHIBITION; VIRUS REACTIVATION;

ADENOSINE MONOPHOSPHATE; ANIMALS; ANTIVIRAL AGENTS; BENZOQUINONES; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; HERPESVIRUS 1, HUMAN; HSP90 HEAT-SHOCK PROTEINS; KERATITIS, HERPETIC; LACTAMS, MACROCYCLIC; MICE; VIRUS ACTIVATION;

EID: 77956166552     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-010-0803-3     Document Type: Review

References (18)

1. Shimomura Y. Reactivation and latency of herpesvirus in the eye. Ophthalmologica 2001;215 suppl 2:15-24.
2. Shimomura Y, Deai T, Fukuda M, Higaki S, Hooper LC, Hayashi K. Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome. Cornea 2007;26:190-193.
3. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent HSV eye disease. N Engl J Med 1998;339:300-306.
4. Kaufman HE, Varnell ED, Gebhardt BM, Thompson HW, Hill JM. Propranolol suppression of ocular HSV-1 recurrence and associated corneal lesions following spontaneous reactivation in the rabbit. Curr Eye Res 1996;15:680-684.
5. Gebhardt BM, Wright GE, Xu H, Focher F, Spadari S, Kaufman HE. 9-(4-Hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in mice. Antiviral Res 1996;30:87-94.
6. Kaufman HE, Varnell ED, Gebhardt BM, et al. Effi cacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection. J Ocul Pharmacol Ther 2008;24:34-42.
7. Myles ME, Azcuy AM, Nguyen NT, et al. Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits. J Pharmacol Exp Ther 2004; 311:640-644.
8. Kurane I, Tsuchiya Y, Sekizawa T, Kumagai K. Inhibition by indomethacin of in vitro reactivation of latent herpes simplex virus type 1 in murine trigeminal ganglia. J Gen Virol 1984;65:1665-1674.
9. Gebhardt BM, Varnell ED, Kaufman HE. Inhibition of cyclooxygenase 2 synthesis suppresses herpes simplex virus type 1 reactivation. J Ocul Pharmacol Ther 2005;21:114-120.
10. Higaki S, Watanabe K, Itahashi M, Shimomura Y. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model. Curr Eye Res 2009;34:171-176.
11. Watanabe K. New therapy to reduce HSV-1 reactivation in mouse model. Kinki Univ Med J 2009;34:3-9.
12. Furuya A, Uozaki M, Yamasaki H, Arakawa T, Arita M, Koyama AH. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. Int J Mol Med 2008;22:541-545.
13. Femiano F, Gombos F, Scully C. Recurrent herpes labialis: a pilot study of the effi cacy of zinc therapy. J Oral Pathol Med 2005;34: 423-425.
14. Millhouse S, Kenny JJ, Quinn PG, Lee V, Wigdahl B. ATF/CREB elements in the herpes simplex virus type 1 latency-associated transcript promoter interact with members of the ATF/CREB and AP-1 transcription factor families. J Biomed Sci 1998;5: 451-464.
15. Necklers LM. Can the heat shock protein 90 inhibitor geldanamycin be designed to specifi cally inhibit HER-2 tyrosine kinase? Drug Resist Updat 2000;3:203-205.
16. Waterbury LD, Silliman D, Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-infl ammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin 2006;22:1133-1140.
17. Sano M. Nonsteroidal anti-infl ammatory drugs. Iyaku J 2003;39: 83-97.
18. Banerjee K, Biswas PS, Rouse BT. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. J Interferon Cytokine Res 2007;27:65-75.